REBECCA EZELL: Open Payments
NPI 1205333622 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$154,094 in 417 payments from 22 companies in 2025. Trend: 2023 $38,354 · 2024 $63,099 · 2025 $154,094
Speaker / faculty: $113,223Travel & lodging: $25,836Food & beverage: $9,211Consulting: $5,790Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 197 | $85,945 |
| Regeneron Healthcare Solutions, Inc. | 80 | $33,398 |
| GENZYME CORPORATION | 51 | $27,551 |
| GlaxoSmithKline, LLC. | 38 | $4,507 |
| Regeneron Pharmaceuticals, Inc. | 2 | $1,392 |
| Grifols USA, LLC | 8 | $326 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $147 |
| United Therapeutics Corporation | 6 | $142 |
| Inspire Medical Systems, Inc. | 2 | $103 |
| Electromed, Inc. | 11 | $93 |
Products named: DUPIXENT, AIRSUPRA, FASENRA, BREZTRI, NUCALA, Prolastin-C Liquid, TEZSPIRE, TRELEGY ELLIPTA.
Industry payments across LA — which companies pay providers there.
